EcoDrugPlus

Ensembl ID : ENSOMYG00000000460
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSOMYG00000044133
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000000500
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSOMYG00000000515
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSOMYG00000000533
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000000634
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOMYG00000000710
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSOMYG00000000708
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSOMYG00000000743
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSOMYG00000002407
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSOMYG00000002443
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOMYG00000042080
Gene Symbol: -
Cross references: -
164 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).